Skip to main content
. 2022 Feb 14;14(2):416. doi: 10.3390/pharmaceutics14020416

Table 1.

Overview of the investigated key attributes of interest for 3D-printed oral dosage forms. Unknown or unpublished data are indicated by “-“.

Printing Technique Dosage Form Active Pharmaceutical Ingredient Assessment of Dose Accuracy Method of Dose Flexibility Target Release Profile Patient Acceptability Dose Administration Ref.
Extrusion-based; non-heated Tablet Spironolactone Content uniformity Volume Similar to commercial tablet: immediate release Accepted by inpatients, family members, doctors, nurses and pharmacists Dissolved in water prior to administration [30]
Hydrochlorothiazide
Orodispersible tablet Levetiracetam Content uniformity Number of layers Immediate release Tablet size not suitable for younger children Orodispersible [31]
Orodispersible film Levocetirizine Content uniformity Volume Immediate release - Orodispersible [32]
Orodispersible film Warfarin Content uniformity Volume Immediate release Acceptable size for children Orodispersible [33]
Administration through feeding tube
Chewable dosage form Paracetamol Drug content assay Filament length Extended release Acceptable palatability Chewable [34]
Ibuprofen
Orodispersible tablet Hydrochlorothiazide Drug content assay - Immediate release - Orodispersible [35]
Orodispersible film Warfarin Drug content assay Volume Immediate release - Orodispersible [36]
Chewable dosage form Lamotrigine - - Immediate release Various colors and shapes Chewable [37]
Acceptable palatability
Tablet Jiuxiang Jianpi Yangwei (JJY) - - - Cartoon shapes - [38]
Acceptable palatability
Extrusion-based; heated Tablet Furosemide Content uniformity Drug concentration Immediate release Size suitable for children Swallowable [39]
Sildenafil
Chewable tablet Isoleucine Drug content assay Volume Immediate release Acceptable palatability; Chewable [40]
Color and flavor patients choice
Chewable dosage form Paracetamol Drug content assay - Paracetamol: immediate release Cartoon shapes Chewable [41]
Acceptable palatability
Ibuprofen Ibuprofen: pH dependent
Pleasant texture
Tablet Caffeine Drug content assay - Modified release Taste masking - [42]
Dependent on infill percentage
Tablet Rufinamide Drug content assay Multiple tablets Enhanced drug release - - [43]
Chewable dosage form Ranitidine Drug content assay - Immediate and modified release Candy shapes Chewable [44]
Dependent on formulation Acceptable palatability
Orodispersible film Diclofenac Drug content assay Surface area Immediate release Taste masking Orodispersible [45]
Tablet Caffeine Mass variation Volume Dependent on tablet dimensions Size suitable for children Swallowable [46]
Propranolol
Tablet Lumefantrine Drug content assay - Immediate release Size suitable for children >6 years Swallowable [47]
Oral dosage form Amiodarone - Filament length - - - [48]
Tablet Praziquantel Drug content assay Drug concentration Enhanced drug release Taste masking - [49]
Tablet Baclofen - Volume Modified release Size suitable for children Swallowable [50]
Chewable tablet Indomethacin - - Immediate release Candy shapes Chewable [51]
Taste masking
Drop-on-powder Tablet Theophylline Content uniformity Volume Similar to commercial tablet: sustained release (theophylline); immediate release (metoprolol tartrate) - - [52]
Drug concentration
Metoprolol tartrate Number of ink spraying times
Orodispersible tablet Levetiracetam - Volume Similar to commercial tablet: immediate release Colorful cartoon shapes Orodispersible [53]
Inkjet Orodispersible film Warfarin Content uniformity Surface area Immediate release Acceptable size for children Orodispersible [33]
Administration through feeding tube
Orodispersible film Metoprolol tartrate Content uniformity Printing resolution - - Orodispersible [54]
Orodispersible film Salbutamol Drug content assay Drug concentration - Size suitable for children Orodispersible [55]
Orodispersible film Clonidine Drug content assay Drug concentration Similar to solvent casting: immediate release - Orodispersible [56]
Orodispersible film Enalapril Drug content assay - - - Orodispersible [57]
Orodispersible film Vitamin B1, B2, B3, B6 Drug content assay Number of ink spraying times - - Orodispersible [58]
Orodispersible film Propranolol Drug content assay Number of ink spraying times Immediate release Acceptable palatability Orodispersible [59]